Lunsekimig Antibody
Lunsekimig (SAR443765) is a bispecific antibody designed for asthma research, combining a nanobody against IL-13 with a VHH domain targeting TSLP. This investigational tool is utilized in preclinical in vitro and in vivo studies to explore mechanisms of dual cytokine inhibition in type 2 inflammatory pathways.
Product Specifications
Target
Others, Interleukin
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog